JENNIFER LORD: Open Payments
NPI 1619353232 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 20 payments from 11 companies in 2025. Trend: 2023 $790 · 2024 $352 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $326 |
| Abbott Laboratories | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 2 | $60 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| United Therapeutics Corporation | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $18 |
Products named: Barostim Neo System, CARDIOMEMS, Kerendia, LifeVest, JARDIANCE, AMVUTTRA, ONPATTRO, Tyvaso.
Industry payments across TX — which companies pay providers there.
